InoCardia (@inocardia) 's Twitter Profile
InoCardia

@inocardia

We provide unique Work Loop models for the assessment of inotropy in human cardiac muscles and primary myocytes.

ID: 1273899468967067649

linkhttp://www.inocardia.co.uk/ calendar_today19-06-2020 08:45:32

10 Tweet

21 Followers

42 Following

Coventry University Research and Innovation (@covuniresearch) 's Twitter Profile Photo

A Coventry University spin-out has been selected to test the safety of new drugs being developed to combat #COVID19. #InoCardia has been awarded £50,000 to ensure the new anti-virals will not cause damage to the heart. Read more: coventry.ac.uk/news/2020/inoc… #CovResearch @CovUni_SELS

A <a href="/covcampus/">Coventry University</a> spin-out has been selected to test the safety of new drugs being developed to combat #COVID19. #InoCardia has been awarded £50,000 to ensure the new anti-virals will not cause damage to the heart. Read more: coventry.ac.uk/news/2020/inoc… #CovResearch @CovUni_SELS
InoCardia (@inocardia) 's Twitter Profile Photo

InoCardia are pleased to announce a collaboration with Cresset Discovery Services to develop improved computational methods for cardiac safety assessment. This collaboration also includes Coventry University, UCB and is supported by EIT Digital. #CardiacSafety #DrugDevelopment

InoCardia (@inocardia) 's Twitter Profile Photo

First of 2 posters at SPS 2020. Development of a Predictive Inotropy In Silico Cardiac Safety Assay for Drug Candidate Screening. Large data set from our WorkLoop assay feeding into the In Silico model. UCB News Cresset Innovate UK

First of 2 posters at <a href="/SafetyPharmSoc/">SPS</a> 2020. Development of a Predictive Inotropy In Silico Cardiac Safety Assay for Drug Candidate Screening. Large data set from our WorkLoop assay feeding into the In Silico model. 
<a href="/ucb_news/">UCB News</a>
<a href="/cressetgroup/">Cresset</a>
<a href="/innovateuk/">Innovate UK</a>
Cresset (@cressetgroup) 's Twitter Profile Photo

Robert Scoffin, CEO, reviews 2020 - from scientific developments, software and services solutions, to the important partnerships we have developed. bit.ly/2IpmPgU #ComputationalChemistry #DrugDiscovery Elixir Software Ltd @ChiroChem InoCardia Open Force Field Initiative 3DNEONET Consortium

Robert Scoffin, CEO, reviews 2020 - from scientific developments, software and services solutions, to the important partnerships we have developed.

bit.ly/2IpmPgU

#ComputationalChemistry #DrugDiscovery <a href="/TrackingBoards/">Elixir Software Ltd</a>  @ChiroChem <a href="/InoCardia/">InoCardia</a> <a href="/openforcefield/">Open Force Field Initiative</a> <a href="/3dneonet/">3DNEONET Consortium</a>
Prof Helen Maddock (@profh_maddock) 's Twitter Profile Photo

Looking forward to giving a talk today about Cancer Treatment-Related Cardiotoxicity & Approaches to Improve Anti-cancer Medication Development #saferdrugs InoCardia @InnovateUK @CovUni_SELS

InoCardia (@inocardia) 's Twitter Profile Photo

The InoCardia team will be attending SPS2021! We have 5 posters (#17, 20, 21, 45, 46), 5 rapid fire presentations, booth 11, and a presentation Thursday 7th October at 12:30pm. Please come along and find out all the new exciting offerings we have. #SPSVirtual2021

The InoCardia team will be attending SPS2021! We have 5 posters (#17, 20, 21, 45, 46), 5 rapid fire presentations, booth 11, and a presentation Thursday 7th October at 12:30pm. Please come along and find out all the new exciting offerings we have. #SPSVirtual2021
InoCardia (@inocardia) 's Twitter Profile Photo

Snapshot from our presentation at SPS #SPSvirtual202 . Showcasing our exciting new pre chemistry In-Silico assay & post chemistry In-Vitro assay. Prof Helen Maddock @CovUni_SELS Innovate UK

Snapshot from our presentation at <a href="/SafetyPharmSoc/">SPS</a> #SPSvirtual202 . Showcasing our exciting new pre chemistry In-Silico assay &amp; post chemistry In-Vitro assay. <a href="/ProfH_Maddock/">Prof Helen Maddock</a> @CovUni_SELS <a href="/innovateuk/">Innovate UK</a>